While there is much excitement surrounding the use of commercial CGM products in management of obesity, our preliminary results suggest that fasting insulin and HOMA-IR values may be more clinically useful than CGM data alone. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.